Prothena
PRTA
$22.63
Share price
0.49%
Change (1 day)
-69.34%
Change (1 year)
Categories
P/S ratio for Prothena (PRTA)
P/S ratio as of May 2024 (TTM): 13.3
According to Prothena's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 13.2532. At the end of 2023 the company had a P/S ratio of 21.3.
P/S ratio history for Prothena from 2013 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 21.3 | -63.01% |
| 2022 | 57.7 | 402.84% |
| 2021 | 11.5 | -97.96% |
| 2020 | 562 | -27.56% |
| 2019 | 776 | 80.47% |
| 2018 | 430 | 720.86% |
| 2017 | 52.4 | -96.74% |
| 2016 | > 1000 | 19.52% |
| 2015 | > 1000 | 11933.6% |
| 2014 | 11.2 | -98.7% |
| 2013 | 857 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Amarin Corporation
AMRN | 1.16 | -91.21% | 🇮🇪 Ireland |
 Alnylam Pharmaceuticals
ALNY | 9.43 | -28.82% | 🇺🇸 USA |
 Alkermes ALKS | 2.46 | -81.46% | 🇮🇪 Ireland |